33725-54-1

Basic information

• Product Name: ferric maltol
• Synonyms: ferric maltol
• CAS NO: 33725-54-1
• Molecular Formula: C₁₈H₁₅FeO₉
• Molecular Weight: 431.1513
• Mol File: 33725-54-1.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 284.7°C at 760 mmHg
• Flash Point: 127.3°C
• Appearance: /
• Vapor Pressure: 0.000337mmHg at 25°C
• CAS DataBase Reference: ferric maltol(CAS DataBase Reference)
• NIST Chemistry Reference: ferric maltol(33725-54-1)
• EPA Substance Registry System: ferric maltol(33725-54-1)

Safety Data

• Hazardous Substances Data: 33725-54-1(Hazardous Substances Data)

Usage

Description

Ferric maltol is an orally active complex of a single iron ion (Fe3+).

Uses

Ferric maltol can be used in the study of iron deficiency anemia in inflammatory bowel disease.

InChI:InChI=1/C6H6O3.Fe/c1-4-6(8)5(7)2-3-9-4;/h2-3,8H,1H3;/q;+3

Upstream product

• 118-71-8 Maltol 
• 121714-78-1 iron(III) chloride hexahydrate 
• 7705-08-0 iron(III) chloride 
• 7439-89-6 iron 

Relevant articles and documents

NOVEL POLYMORPHIC FORM OF FERRIC MALTOL

The present application generally provides ferric maltol of formula I, and more particularly a crystalline form alfa of Ferric maltol, which is characterized by its PXRD pattern as illustrated herein. Corresponding methods for producing the ferric maltol disclosed herein are also provided.

METHODS FOR PRODUCING FERRIC MALTOL COMPOSITIONS FROM LIGAND MODIFIED AND LIGAND COATED FERRIC HYDROXIDES

Methods for producing ferric maltol compositions, such as ferric trimaltol,are described in which maltolis reacted with a ligand modified ferric hydroxide and/or a ligand coated ferric hydroxide.

A Potential Iron Pharmaceutical Composition for the Treatment of Iron-deficiency Anaemia. The Crystal and Molecular Structure of mer-Tris-(3-hydroxy-2-methyl-4H-pyran-4-onato)iron(III)

mer-Tris(3-hydroxy-2-methyl-4H-pyran-4-onato)iron(III) has potential use in the treatment of iron-deficiency anaemia.It displays the ideal properties that a new iron chelation complex must possess to be an effective treatment.These properties are discussed.The crystal and molecular structure of this complex has been determined from single-crystal X-ray diffraction data and refined by least squares to R=0.0649 for 2735 independent reflections.The compounds crystallizes in the monoclinic space group P21/c with cell dimensions a=7.369(1), b=14.720(3), and c=19.964(5) Angstroem, β=100.41(2) deg, Z=4.The iron atom lies in a distorted octahedral environment with the three ligands bonded through the hydroxy and ketone oxygen atoms to give the mer configuration.Variable-temperature 57Fe Moessbauer data for the complex are reported and the results are discussed in relation to the structure.